Society Letters

Endocrine Society Comments on EPA Transparency Rule

April 06, 2020

To: The Honorable Andrew Wheeler

"The supplement to the notice expands the scope of the original rule such that the provisions will apply not only to the dose-response data and models, but to all data and models “underlying pivotal regulatory science and pivotal science which support significant regulatory decisions and influential scientific information.”  Furthermore, the rule would also apply to historical data and analyses, which would potentially remove from consideration well-supported studies that were conducted under specific confidentiality agreements to protect participant privacy.  This expansion of scope to encompass essentially all scientific information considered by the agency, in the context of nearly any potential rulemaking or revisions, is highly problematic given that many fundamental questions remain concerning how the agency will apply the rule to important sources of data.  "

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!